2015 Q4 Form 10-Q Financial Statement

#000119312515360248 Filed on October 30, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $55.87M $53.84M $44.53M
YoY Change 23.22% 20.91% 32.28%
Cost Of Revenue $23.63M $23.13M $19.12M
YoY Change 21.99% 20.98% 35.64%
Gross Profit $32.23M $30.71M $25.41M
YoY Change 24.1% 20.85% 29.86%
Gross Profit Margin 57.69% 57.04% 57.07%
Selling, General & Admin $17.95M $15.55M $13.64M
YoY Change 25.17% 13.98% 30.69%
% of Gross Profit 55.69% 50.64% 53.69%
Research & Development $7.560M $6.195M $4.211M
YoY Change 71.43% 47.11% 31.18%
% of Gross Profit 23.46% 20.17% 16.57%
Depreciation & Amortization $4.850M $4.639M $2.815M
YoY Change 62.21% 64.8% 38.06%
% of Gross Profit 15.05% 15.11% 11.08%
Operating Expenses $30.36M $6.195M $17.85M
YoY Change 39.65% -65.3% 30.81%
Operating Profit $1.870M $4.325M $4.741M
YoY Change -55.79% -8.77% 22.22%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $170.0K $28.00K $49.00K
YoY Change 466.67% -42.86% 6.52%
Pretax Income $2.050M $4.353M $4.790M
YoY Change -51.88% -9.12% 22.04%
Income Tax $240.0K $1.739M $1.354M
% Of Pretax Income 11.71% 39.95% 28.27%
Net Earnings $1.810M $2.614M $3.436M
YoY Change -31.7% -23.92% 49.65%
Net Earnings / Revenue 3.24% 4.86% 7.72%
Basic Earnings Per Share $0.08 $0.12
Diluted Earnings Per Share $56.51K $0.08 $0.12
COMMON SHARES
Basic Shares Outstanding 31.65M shares 31.64M shares 27.61M shares
Diluted Shares Outstanding 32.03M shares 28.05M shares

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.0M $144.8M $116.4M
YoY Change 23.14% 24.4% 11.17%
Cash & Equivalents $82.01M $67.44M $64.93M
Short-Term Investments $67.00M $77.40M $51.50M
Other Short-Term Assets $8.169M $6.649M $3.566M
YoY Change 41.63% 86.46% 11.58%
Inventory
Prepaid Expenses
Receivables $36.35M $33.12M $28.18M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $209.5M $201.7M $162.9M
YoY Change 20.0% 23.78% 15.85%
LONG-TERM ASSETS
Property, Plant & Equipment $12.47M $11.85M $9.007M
YoY Change 32.08% 31.53% 14.45%
Goodwill $83.07M $84.00M $42.65M
YoY Change 98.2% 96.93% 25.29%
Intangibles
YoY Change
Long-Term Investments $3.600M $3.700M
YoY Change 100.0%
Other Assets $927.0K $1.752M $984.0K
YoY Change -54.49% 78.05% 19.42%
Total Long-Term Assets $170.0M $173.0M $80.40M
YoY Change 105.72% 115.23% 25.32%
TOTAL ASSETS
Total Short-Term Assets $209.5M $201.7M $162.9M
Total Long-Term Assets $170.0M $173.0M $80.40M
Total Assets $379.6M $374.7M $243.3M
YoY Change 47.54% 53.99% 18.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.616M $2.251M $799.0K
YoY Change -2.88% 181.73% -56.76%
Accrued Expenses $7.003M $7.672M $11.76M
YoY Change -3.06% -34.77% 55.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $89.08M $85.47M $74.44M
YoY Change 15.3% 14.83% 36.97%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.058M $766.0K $710.0K
YoY Change -60.06% 7.89% 10.42%
Total Long-Term Liabilities $1.058M $766.0K $710.0K
YoY Change -60.06% 7.89% 10.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $89.08M $85.47M $74.44M
Total Long-Term Liabilities $1.058M $766.0K $710.0K
Total Liabilities $90.14M $86.24M $75.15M
YoY Change 12.8% 14.76% 36.66%
SHAREHOLDERS EQUITY
Retained Earnings $1.591M -$220.0K -$9.677M
YoY Change -122.63% -97.73% -49.56%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $280.3M $278.8M $161.2M
YoY Change
Total Liabilities & Shareholders Equity $379.6M $374.7M $243.3M
YoY Change 47.54% 53.99% 18.81%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $1.810M $2.614M $3.436M
YoY Change -31.7% -23.92% 49.65%
Depreciation, Depletion And Amortization $4.850M $4.639M $2.815M
YoY Change 62.21% 64.8% 38.06%
Cash From Operating Activities $9.400M $6.390M $6.580M
YoY Change 68.46% -2.89% -44.47%
INVESTING ACTIVITIES
Capital Expenditures -$4.020M -$3.720M -$1.960M
YoY Change 28.43% 89.8% -9.68%
Acquisitions
YoY Change
Other Investing Activities $9.910M $6.520M -$820.0K
YoY Change -11.44% -895.12% -92.18%
Cash From Investing Activities $5.890M $2.800M -$2.770M
YoY Change -26.92% -201.08% -78.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -720.0K 3.760M 260.0K
YoY Change -120.99% 1346.15% -79.37%
NET CHANGE
Cash From Operating Activities 9.400M 6.390M 6.580M
Cash From Investing Activities 5.890M 2.800M -2.770M
Cash From Financing Activities -720.0K 3.760M 260.0K
Net Change In Cash 14.57M 12.95M 4.070M
YoY Change -14.65% 218.18% 804.44%
FREE CASH FLOW
Cash From Operating Activities $9.400M $6.390M $6.580M
Capital Expenditures -$4.020M -$3.720M -$1.960M
Free Cash Flow $13.42M $10.11M $8.540M
YoY Change 54.08% 18.38% -39.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2615000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
278756000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
766000
CY2015Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17811000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64927000
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31646000 shares
CY2015Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31646000 shares
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
308000
CY2015Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
115000
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
64931000
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2251000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
330000
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7672000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-220000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
374717000
CY2015Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3893000
CY2015Q3 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
279023000
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29875000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
85473000
CY2015Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8004000
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47000
CY2015Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5829000
CY2015Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
22380000
CY2015Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
30286000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1752000
CY2015Q3 us-gaap Prepaid Royalties
PrepaidRoyalties
13976000
CY2015Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
13768000
CY2015Q3 us-gaap Acquired Finite Lived Intangible Asset Residual Value
AcquiredFiniteLivedIntangibleAssetResidualValue
47200000
CY2015Q3 us-gaap Assets
Assets
374717000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33124000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11847000
CY2015Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
77367000
CY2015Q3 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2054000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
201674000
CY2015Q3 us-gaap Other Assets Current
OtherAssetsCurrent
6649000
CY2015Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
5135000
CY2015Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58018000
CY2015Q3 us-gaap Goodwill
Goodwill
84000000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67441000
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
41722000
CY2015Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
6301000
CY2015Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3658000
CY2015Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1063000
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31645933 shares
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59537000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27677000 shares
CY2014Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27677000 shares
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2311000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
167859000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2649000
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13834000
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
53716000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4753000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
331000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7224000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7030000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
257262000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3657000
CY2014Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
174926000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
26105000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77259000
CY2014Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
25133000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2037000
CY2014Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
13030000
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
12706000
CY2014Q4 us-gaap Assets
Assets
257262000
CY2014Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9255000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2014Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5838000
CY2014Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
18114000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33167000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9442000
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
38973000
CY2014Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1678000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
174611000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5414000
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
4554000
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
14795000
CY2014Q4 us-gaap Goodwill
Goodwill
41914000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81995000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35547000
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
5860000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1757000
CY2014Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
354000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
28675000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
93000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27999000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
457000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27542000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.368 pure
us-gaap Payments For Software
PaymentsForSoftware
4025000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3044000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-129000
us-gaap Net Income Loss
NetIncomeLoss
7747000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
160000
us-gaap Sales Revenue Net
SalesRevenueNet
125351000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
260000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12298000
us-gaap Operating Income Loss
OperatingIncomeLoss
12149000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-79000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
117000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
3975000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
44324000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
325000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
10000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
270000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7757000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
10000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1891000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12266000
us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
670000
us-gaap Stock Issued1
StockIssued1
2247000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-34000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4519000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14918000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21783000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
16651000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5390000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-23598000
us-gaap Costs And Expenses
CostsAndExpenses
113202000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
313000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12052000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4519000
us-gaap Other Noncash Expense
OtherNoncashExpense
1082000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
288000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
872000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1222000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
-129000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
40418000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1511000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1814000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7938000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
54778000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
170000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
25519000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-1800000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Amendment Flag
AmendmentFlag
false
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29905000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
378000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29527000 shares
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Trading Symbol
TradingSymbol
HSTM
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.417 pure
us-gaap Payments For Software
PaymentsForSoftware
5329000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6012000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3721000
us-gaap Net Income Loss
NetIncomeLoss
6810000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
753000
us-gaap Sales Revenue Net
SalesRevenueNet
153136000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2787000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
98014000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
595000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
88075000
us-gaap Operating Income Loss
OperatingIncomeLoss
11679000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-288000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1000000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
946000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
77774000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-10000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
3721000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
633000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6800000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-10000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2649000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11672000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-425000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
28000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-98000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4862000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5426000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
26052000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
20851000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14554000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-140750000
us-gaap Costs And Expenses
CostsAndExpenses
141457000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
100677000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16654000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
123000
us-gaap Other Noncash Expense
OtherNoncashExpense
938000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98014000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3082000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
328000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2787000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
28000000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3721000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
38440000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2501000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1251000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12148000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
65752000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
184000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
42086000
hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
41000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28047000 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
442000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27605000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
3436000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
44525000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4741000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
49000
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3423000
CY2014Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-13000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4790000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1354000
CY2014Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7585000
CY2014Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6058000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
39784000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4211000
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31643000 shares
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
2614000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
53835000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4325000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
388000
CY2014Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2815000
CY2014Q3 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
19115000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32029000 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
386000 shares
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
31000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2645000
CY2015Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
31000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4353000
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1739000
CY2015Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8377000
CY2015Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
7173000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
49510000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6195000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
440000
CY2015Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4639000
CY2015Q3 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
23126000

Files In Submission

Name View Source Status
0001193125-15-360248-index-headers.html Edgar Link pending
0001193125-15-360248-index.html Edgar Link pending
0001193125-15-360248.txt Edgar Link pending
0001193125-15-360248-xbrl.zip Edgar Link pending
d81538d10q.htm Edgar Link pending
d81538dex101.htm Edgar Link pending
d81538dex102.htm Edgar Link pending
d81538dex103.htm Edgar Link pending
d81538dex104.htm Edgar Link pending
d81538dex311.htm Edgar Link pending
d81538dex312.htm Edgar Link pending
d81538dex321.htm Edgar Link pending
d81538dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g81538g39x16.jpg Edgar Link pending
g81538g50t94.jpg Edgar Link pending
hstm-20150930.xml Edgar Link completed
hstm-20150930.xsd Edgar Link pending
hstm-20150930_cal.xml Edgar Link unprocessable
hstm-20150930_def.xml Edgar Link unprocessable
hstm-20150930_lab.xml Edgar Link unprocessable
hstm-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending